sihuan pharmaceutical

Morgan Stanley raises $1.7b for Asia deals

Morgan Stanley’s fourth Asia private equity fund is mainly targeting deals in China. It has a South Korean and an Indian transaction already in the bag.

July 07, 2014

Luye Pharma locks in IPO cornerstones

The Chinese healthcare company began taking institutional orders on Monday, with the book already multiple times covered.

June 23, 2014

Retail investors flock to IPO by Chinese menswear brand

Evergreen International's retail tranche is 1,231 times covered, making it the most heavily oversubscribed retail offering so far this year.

October 28, 2010

Sihuan Pharma prices second largest healthcare IPO this year

The Chinese manufacturer of cardio-cerebral vascular drugs raises $741 million by pricing its shares at 26.7 times next year's earnings, making it the most expensive new stock to list in Hong Kong this year.

October 21, 2010

Sihuan Pharmaceutical aims to raise $740 million in Hong Kong IPO

If successful, this will be the second Chinese medical company in the past month to transfer listings from another stock exchange to Hong Kong.

October 12, 2010